Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allakos Inc. | Director | Stock Option (Right to buy) | 155K | Aug 1, 2023 | Direct | ||
Krystal Biotech, Inc. | Director | Stock Option (Right to Buy) | 5K | Jun 30, 2024 | Direct | ||
Translate Bio, Inc. | President | Stock Option (right to buy) | 0 | Sep 14, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UPB | Upstream Bio, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 10, 2024 | Chief Executive Officer, Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
ALLK | Allakos Inc. | Aug 1, 2023 | 1 | $0 | 4 | Aug 3, 2023 | Director |
ALLK | Allakos Inc. | Jul 31, 2023 | 0 | $0 | 3 | Aug 3, 2023 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
KRYS | Krystal Biotech, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Director |
KRYS | Krystal Biotech, Inc. | Jan 18, 2022 | 0 | $0 | 3 | Jan 26, 2022 | Director |
TBIO | Translate Bio, Inc. | Sep 14, 2021 | 1 | $0 | 4 | Sep 14, 2021 | President |